Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Small Molecule Libraries | 17 | 2019 | 733 | 1.350 |
Why?
|
Interleukin-10 | 2 | 2017 | 1172 | 0.420 |
Why?
|
Cyclin-Dependent Kinase 8 | 2 | 2021 | 48 | 0.340 |
Why?
|
Drug Discovery | 8 | 2016 | 1051 | 0.320 |
Why?
|
High-Throughput Screening Assays | 8 | 2017 | 933 | 0.310 |
Why?
|
Immunologic Factors | 2 | 2014 | 1589 | 0.300 |
Why?
|
Molecular Probes | 3 | 2016 | 309 | 0.300 |
Why?
|
Drug Evaluation, Preclinical | 6 | 2017 | 1333 | 0.300 |
Why?
|
Drug Screening Assays, Antitumor | 5 | 2016 | 717 | 0.270 |
Why?
|
Cytokines | 4 | 2015 | 7373 | 0.260 |
Why?
|
Fluorescent Dyes | 1 | 2013 | 1901 | 0.250 |
Why?
|
Protein Kinase Inhibitors | 5 | 2019 | 5672 | 0.250 |
Why?
|
CARD Signaling Adaptor Proteins | 2 | 2017 | 159 | 0.250 |
Why?
|
Glutathione Peroxidase | 3 | 2017 | 258 | 0.250 |
Why?
|
Cell Line, Tumor | 23 | 2019 | 16967 | 0.240 |
Why?
|
Dendritic Cells | 2 | 2015 | 2722 | 0.230 |
Why?
|
Dioxolanes | 3 | 2013 | 23 | 0.230 |
Why?
|
Autophagy | 4 | 2015 | 1326 | 0.210 |
Why?
|
Autoimmune Diseases | 1 | 2014 | 2238 | 0.200 |
Why?
|
Growth Substances | 1 | 2003 | 768 | 0.190 |
Why?
|
Myeloid Cells | 2 | 2017 | 823 | 0.180 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2017 | 8998 | 0.180 |
Why?
|
GATA3 Transcription Factor | 1 | 2021 | 154 | 0.180 |
Why?
|
Enzyme Inhibitors | 6 | 2015 | 3705 | 0.180 |
Why?
|
Drug Resistance, Neoplasm | 7 | 2017 | 5304 | 0.180 |
Why?
|
Isoquinolines | 1 | 2021 | 352 | 0.170 |
Why?
|
Structure-Activity Relationship | 7 | 2017 | 3074 | 0.170 |
Why?
|
Neoplasms | 11 | 2017 | 22131 | 0.170 |
Why?
|
Computational Biology | 3 | 2016 | 3509 | 0.160 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2019 | 223 | 0.150 |
Why?
|
Rhabdoid Tumor | 1 | 2019 | 210 | 0.140 |
Why?
|
Immunophenotyping | 1 | 2021 | 1865 | 0.130 |
Why?
|
Cell Survival | 6 | 2016 | 5780 | 0.130 |
Why?
|
Carrier Proteins | 5 | 2015 | 4935 | 0.130 |
Why?
|
Lipid Peroxidation | 1 | 2017 | 271 | 0.130 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2015 | 20 | 0.130 |
Why?
|
Reactive Oxygen Species | 3 | 2013 | 2137 | 0.130 |
Why?
|
Receptors, Endothelin | 1 | 2015 | 56 | 0.130 |
Why?
|
Candidiasis, Invasive | 1 | 2015 | 23 | 0.130 |
Why?
|
Karyopherins | 1 | 2016 | 133 | 0.130 |
Why?
|
Quinolines | 2 | 2014 | 764 | 0.130 |
Why?
|
Receptors, Angiotensin | 1 | 2015 | 141 | 0.130 |
Why?
|
Niemann-Pick Disease, Type C | 1 | 2015 | 49 | 0.120 |
Why?
|
Cytotoxins | 1 | 2015 | 153 | 0.120 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2016 | 132 | 0.120 |
Why?
|
Gene Expression Profiling | 6 | 2017 | 9417 | 0.120 |
Why?
|
Cell Death | 3 | 2017 | 1677 | 0.120 |
Why?
|
Mice, Inbred BALB C | 4 | 2021 | 6188 | 0.120 |
Why?
|
Nicotinamide Phosphoribosyltransferase | 1 | 2014 | 83 | 0.110 |
Why?
|
Forkhead Transcription Factors | 1 | 2021 | 1614 | 0.110 |
Why?
|
Pyridazines | 1 | 2015 | 201 | 0.110 |
Why?
|
Antineoplastic Agents | 7 | 2019 | 13635 | 0.110 |
Why?
|
Paneth Cells | 1 | 2014 | 98 | 0.110 |
Why?
|
Mice | 21 | 2021 | 81368 | 0.110 |
Why?
|
Signal Transduction | 9 | 2021 | 23416 | 0.110 |
Why?
|
Salmonella Infections, Animal | 1 | 2013 | 60 | 0.110 |
Why?
|
Vacuolar Proton-Translocating ATPases | 1 | 2015 | 195 | 0.110 |
Why?
|
HeLa Cells | 6 | 2015 | 3087 | 0.110 |
Why?
|
Azacitidine | 1 | 2015 | 335 | 0.110 |
Why?
|
Molecular Structure | 5 | 2017 | 1878 | 0.110 |
Why?
|
Inflammatory Bowel Diseases | 3 | 2017 | 2423 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 3800 | 0.100 |
Why?
|
Salmonella Infections | 1 | 2014 | 172 | 0.100 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2015 | 3077 | 0.100 |
Why?
|
Genetics, Medical | 1 | 2015 | 334 | 0.100 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2016 | 561 | 0.100 |
Why?
|
Genes, ras | 1 | 2015 | 654 | 0.100 |
Why?
|
Immune Tolerance | 1 | 2021 | 2299 | 0.100 |
Why?
|
Animals | 24 | 2021 | 168201 | 0.100 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2014 | 502 | 0.100 |
Why?
|
Carbolines | 1 | 2014 | 295 | 0.100 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 858 | 0.100 |
Why?
|
Th17 Cells | 2 | 2015 | 793 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2016 | 8542 | 0.090 |
Why?
|
Phenylurea Compounds | 1 | 2014 | 529 | 0.090 |
Why?
|
Cerebellar Neoplasms | 1 | 2016 | 586 | 0.090 |
Why?
|
Rare Diseases | 1 | 2016 | 622 | 0.090 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2015 | 473 | 0.090 |
Why?
|
Medulloblastoma | 1 | 2016 | 677 | 0.090 |
Why?
|
Gene Expression Regulation, Fungal | 2 | 2004 | 493 | 0.090 |
Why?
|
Glucagon-Secreting Cells | 1 | 2010 | 42 | 0.090 |
Why?
|
Mice, Nude | 4 | 2019 | 3605 | 0.090 |
Why?
|
Phosphorylation | 5 | 2021 | 8311 | 0.090 |
Why?
|
Piperazines | 3 | 2016 | 2521 | 0.080 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2017 | 1894 | 0.080 |
Why?
|
Lysosomes | 1 | 2015 | 924 | 0.080 |
Why?
|
Nitriles | 1 | 2014 | 971 | 0.080 |
Why?
|
Aniline Compounds | 1 | 2014 | 1068 | 0.080 |
Why?
|
Protein Array Analysis | 1 | 2010 | 399 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 4366 | 0.080 |
Why?
|
Adaptive Immunity | 1 | 2013 | 724 | 0.080 |
Why?
|
Hedgehog Proteins | 1 | 2013 | 768 | 0.080 |
Why?
|
DNA Damage | 2 | 2016 | 2446 | 0.080 |
Why?
|
Islets of Langerhans | 2 | 2011 | 1340 | 0.080 |
Why?
|
Intestine, Small | 1 | 2014 | 1207 | 0.080 |
Why?
|
Models, Biological | 4 | 2016 | 9461 | 0.070 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2012 | 682 | 0.070 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2007 | 103 | 0.070 |
Why?
|
Cell Line | 7 | 2017 | 15576 | 0.070 |
Why?
|
Quinolones | 1 | 2010 | 378 | 0.070 |
Why?
|
Thiazoles | 1 | 2014 | 1517 | 0.070 |
Why?
|
Humans | 41 | 2021 | 760617 | 0.070 |
Why?
|
Immunity, Innate | 2 | 2021 | 3045 | 0.070 |
Why?
|
Sirolimus | 2 | 2004 | 1533 | 0.070 |
Why?
|
Oxidative Stress | 3 | 2013 | 3113 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2016 | 3634 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2016 | 3599 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2015 | 2425 | 0.060 |
Why?
|
Transcription, Genetic | 3 | 2012 | 7583 | 0.060 |
Why?
|
Neoplastic Stem Cells | 1 | 2013 | 1350 | 0.060 |
Why?
|
Inflammation Mediators | 1 | 2014 | 1884 | 0.060 |
Why?
|
Leukemia | 1 | 2013 | 1520 | 0.060 |
Why?
|
Cells, Cultured | 3 | 2017 | 18937 | 0.060 |
Why?
|
Mice, Transgenic | 2 | 2015 | 9529 | 0.060 |
Why?
|
Pancreas | 1 | 2012 | 1690 | 0.060 |
Why?
|
Sarcoma | 1 | 2016 | 1800 | 0.060 |
Why?
|
Transcription Factors | 3 | 2014 | 12116 | 0.060 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2007 | 287 | 0.060 |
Why?
|
Cell Differentiation | 3 | 2021 | 11514 | 0.060 |
Why?
|
Homeostasis | 1 | 2015 | 3321 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2017 | 10754 | 0.060 |
Why?
|
CCAAT-Binding Factor | 1 | 2003 | 21 | 0.060 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 2004 | 1836 | 0.060 |
Why?
|
Cluster Analysis | 3 | 2015 | 2700 | 0.050 |
Why?
|
Blotting, Western | 3 | 2015 | 5034 | 0.050 |
Why?
|
Mice, Knockout | 5 | 2016 | 14389 | 0.050 |
Why?
|
Mice, Inbred C57BL | 3 | 2017 | 22115 | 0.050 |
Why?
|
Dioxanes | 1 | 2002 | 36 | 0.050 |
Why?
|
Intestinal Mucosa | 1 | 2013 | 3031 | 0.050 |
Why?
|
Genetic Variation | 1 | 2017 | 6561 | 0.050 |
Why?
|
Apoptosis | 3 | 2016 | 9476 | 0.050 |
Why?
|
Pyrimidines | 1 | 2014 | 3027 | 0.050 |
Why?
|
Gene Expression Regulation | 3 | 2014 | 11874 | 0.050 |
Why?
|
Crohn Disease | 1 | 2014 | 2279 | 0.050 |
Why?
|
Neoplasm Transplantation | 2 | 2016 | 2010 | 0.050 |
Why?
|
Mutation | 5 | 2019 | 30016 | 0.050 |
Why?
|
Oxazoles | 1 | 2002 | 199 | 0.050 |
Why?
|
STAT Transcription Factors | 1 | 2021 | 188 | 0.050 |
Why?
|
Amides | 1 | 2003 | 449 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2021 | 287 | 0.040 |
Why?
|
Prions | 1 | 2002 | 180 | 0.040 |
Why?
|
Chromatin | 1 | 2012 | 2955 | 0.040 |
Why?
|
Histone Deacetylases | 1 | 2004 | 719 | 0.040 |
Why?
|
Insulin | 2 | 2011 | 6593 | 0.040 |
Why?
|
Fungal Proteins | 1 | 2003 | 907 | 0.040 |
Why?
|
Sequence Analysis, RNA | 2 | 2017 | 2014 | 0.040 |
Why?
|
Interleukin-1beta | 2 | 2015 | 998 | 0.040 |
Why?
|
Models, Theoretical | 1 | 2010 | 3567 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2019 | 4269 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2015 | 4849 | 0.040 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2014 | 774 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2007 | 2864 | 0.040 |
Why?
|
Breast Neoplasms | 3 | 2015 | 20988 | 0.040 |
Why?
|
Lipid Peroxides | 1 | 2017 | 74 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2016 | 17878 | 0.040 |
Why?
|
Tumor Cells, Cultured | 2 | 2015 | 6126 | 0.030 |
Why?
|
Cells | 1 | 2017 | 164 | 0.030 |
Why?
|
Cell Transdifferentiation | 1 | 2017 | 186 | 0.030 |
Why?
|
Aflatoxins | 1 | 2015 | 12 | 0.030 |
Why?
|
Saccharomyces cerevisiae | 2 | 2004 | 2674 | 0.030 |
Why?
|
Cell Division | 1 | 2003 | 4457 | 0.030 |
Why?
|
Glucose | 2 | 2011 | 4345 | 0.030 |
Why?
|
Repressor Proteins | 2 | 2004 | 2985 | 0.030 |
Why?
|
Harmine | 1 | 2015 | 11 | 0.030 |
Why?
|
Proteins | 1 | 2010 | 6030 | 0.030 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2015 | 221 | 0.030 |
Why?
|
Genomics | 3 | 2016 | 5822 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2016 | 465 | 0.030 |
Why?
|
Radiation, Ionizing | 1 | 2016 | 251 | 0.030 |
Why?
|
Cell Aggregation | 1 | 2015 | 239 | 0.030 |
Why?
|
RNA Interference | 2 | 2016 | 2830 | 0.030 |
Why?
|
Protein Binding | 3 | 2017 | 9345 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2015 | 370 | 0.030 |
Why?
|
Hydrazines | 1 | 2016 | 223 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2014 | 15908 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2012 | 6340 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2003 | 2446 | 0.030 |
Why?
|
Drug Delivery Systems | 2 | 2015 | 2222 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 2012 | 5367 | 0.030 |
Why?
|
Pyridines | 2 | 2016 | 2874 | 0.030 |
Why?
|
Mesoderm | 1 | 2017 | 674 | 0.030 |
Why?
|
Macrolides | 1 | 2015 | 204 | 0.030 |
Why?
|
Radiation Tolerance | 1 | 2016 | 478 | 0.030 |
Why?
|
Insulin-Secreting Cells | 2 | 2011 | 898 | 0.030 |
Why?
|
Buthionine Sulfoximine | 1 | 2013 | 17 | 0.030 |
Why?
|
Lovastatin | 1 | 2013 | 115 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2016 | 4910 | 0.030 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2014 | 274 | 0.030 |
Why?
|
Genes, Dominant | 1 | 2015 | 851 | 0.030 |
Why?
|
Organ Specificity | 1 | 2017 | 1964 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2003 | 2895 | 0.030 |
Why?
|
Alkenes | 1 | 2012 | 54 | 0.030 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2014 | 295 | 0.030 |
Why?
|
Gene Knock-In Techniques | 1 | 2014 | 420 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2015 | 943 | 0.030 |
Why?
|
Cadherins | 1 | 2017 | 901 | 0.030 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2016 | 655 | 0.030 |
Why?
|
Immunoblotting | 1 | 2015 | 1646 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2017 | 737 | 0.030 |
Why?
|
Computer Simulation | 2 | 2016 | 6233 | 0.030 |
Why?
|
Proteomics | 2 | 2017 | 3836 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 2 | 2015 | 3730 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2017 | 20074 | 0.020 |
Why?
|
Protein Interaction Mapping | 1 | 2015 | 615 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2003 | 3447 | 0.020 |
Why?
|
Phenotype | 3 | 2015 | 16571 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2013 | 866 | 0.020 |
Why?
|
Comet Assay | 1 | 2011 | 75 | 0.020 |
Why?
|
Automation | 1 | 2014 | 585 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2015 | 794 | 0.020 |
Why?
|
Drug Synergism | 1 | 2015 | 1755 | 0.020 |
Why?
|
Glutathione | 1 | 2014 | 582 | 0.020 |
Why?
|
Genetic Markers | 1 | 2017 | 2601 | 0.020 |
Why?
|
Down-Regulation | 2 | 2012 | 2915 | 0.020 |
Why?
|
Salmonella typhimurium | 1 | 2013 | 347 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2014 | 3777 | 0.020 |
Why?
|
Sulfhydryl Compounds | 1 | 2012 | 301 | 0.020 |
Why?
|
Goblet Cells | 1 | 2014 | 298 | 0.020 |
Why?
|
Histocompatibility Antigens | 1 | 2012 | 464 | 0.020 |
Why?
|
Ubiquitination | 1 | 2015 | 1006 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2015 | 1697 | 0.020 |
Why?
|
Triazoles | 1 | 2016 | 903 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2016 | 988 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2014 | 982 | 0.020 |
Why?
|
Models, Chemical | 1 | 2012 | 611 | 0.020 |
Why?
|
Adjuvants, Immunologic | 1 | 2015 | 990 | 0.020 |
Why?
|
Random Allocation | 1 | 2014 | 2392 | 0.020 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2010 | 203 | 0.020 |
Why?
|
Disease Models, Animal | 3 | 2016 | 18221 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2015 | 3591 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2015 | 2063 | 0.020 |
Why?
|
Doxorubicin | 1 | 2016 | 2224 | 0.020 |
Why?
|
Pharmaceutical Preparations | 1 | 2017 | 1086 | 0.020 |
Why?
|
Tissue Culture Techniques | 1 | 2010 | 289 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 1608 | 0.020 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2010 | 296 | 0.020 |
Why?
|
Data Mining | 1 | 2014 | 551 | 0.020 |
Why?
|
Iron | 1 | 2017 | 1790 | 0.020 |
Why?
|
Neural Stem Cells | 1 | 2016 | 887 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2015 | 3792 | 0.020 |
Why?
|
Th1 Cells | 1 | 2013 | 1027 | 0.020 |
Why?
|
Gene Expression | 2 | 2012 | 7568 | 0.020 |
Why?
|
Cell Lineage | 1 | 2017 | 2554 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 2013 | 1074 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2013 | 1130 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2015 | 10432 | 0.020 |
Why?
|
Cell Cycle | 1 | 2016 | 2930 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2014 | 1186 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2015 | 1662 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2015 | 1971 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2017 | 2057 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 2020 | 0.020 |
Why?
|
Ribosomal Protein S6 | 1 | 2007 | 71 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2016 | 2456 | 0.020 |
Why?
|
Osteosarcoma | 1 | 2013 | 896 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4570 | 0.020 |
Why?
|
Lymphoma, B-Cell | 1 | 2014 | 938 | 0.020 |
Why?
|
Colitis | 1 | 2015 | 1234 | 0.020 |
Why?
|
Benzimidazoles | 1 | 2012 | 858 | 0.020 |
Why?
|
Benzamides | 1 | 2012 | 1371 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2012 | 1988 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2014 | 2326 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2016 | 2917 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2872 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2007 | 704 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2015 | 3688 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2014 | 12758 | 0.010 |
Why?
|
Bacteria | 1 | 2015 | 2192 | 0.010 |
Why?
|
Models, Molecular | 1 | 2014 | 5433 | 0.010 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2015 | 1850 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2014 | 5863 | 0.010 |
Why?
|
Pyrans | 1 | 2003 | 49 | 0.010 |
Why?
|
Peptides | 1 | 2015 | 4354 | 0.010 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2003 | 135 | 0.010 |
Why?
|
Up-Regulation | 1 | 2012 | 4117 | 0.010 |
Why?
|
Genes, Fungal | 1 | 2004 | 439 | 0.010 |
Why?
|
Surface Plasmon Resonance | 1 | 2003 | 269 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14648 | 0.010 |
Why?
|
Gene Regulatory Networks | 1 | 2010 | 1745 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2011 | 2821 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 3419 | 0.010 |
Why?
|
Alleles | 1 | 2012 | 6861 | 0.010 |
Why?
|
Glutathione Transferase | 1 | 2003 | 565 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2013 | 3394 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 2013 | 2527 | 0.010 |
Why?
|
Female | 5 | 2019 | 392148 | 0.010 |
Why?
|
Protein Kinases | 1 | 2007 | 1606 | 0.010 |
Why?
|
Software | 1 | 2014 | 4431 | 0.010 |
Why?
|
Melanoma | 1 | 2017 | 5697 | 0.010 |
Why?
|
Carcinoma, Renal Cell | 1 | 2014 | 3164 | 0.010 |
Why?
|
Macrophages | 1 | 2013 | 5758 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 3244 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2010 | 3607 | 0.010 |
Why?
|
Protein Transport | 1 | 2004 | 1966 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2002 | 1790 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2007 | 2057 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2016 | 9277 | 0.010 |
Why?
|
Genotype | 1 | 2011 | 12978 | 0.010 |
Why?
|
Neurons | 1 | 2015 | 9438 | 0.010 |
Why?
|
Kinetics | 1 | 2003 | 6370 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 11736 | 0.010 |
Why?
|
Ligands | 1 | 2002 | 3268 | 0.010 |
Why?
|
United States | 2 | 2015 | 72272 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 59179 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2017 | 11106 | 0.010 |
Why?
|
Prognosis | 1 | 2015 | 29600 | 0.010 |
Why?
|
Algorithms | 1 | 2014 | 14018 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 88234 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2004 | 5780 | 0.010 |
Why?
|
Middle Aged | 1 | 2021 | 220584 | 0.000 |
Why?
|
Adult | 1 | 2021 | 220969 | 0.000 |
Why?
|
Male | 1 | 2017 | 360358 | 0.000 |
Why?
|